Organ Transplantation Research Today is a free monthly online journal that collates and summarizes the latest research about Organ Transplantation, including details on risks, prognosis, procedure, surgery.

Volume 2 (2005), Issue 8 (August)

1. Effects of the placement of endosseous implants in vascularized bone grafts on bone union in beagle dogs.
   Int J Oral Maxillofac Surg, 34(6): 659-67. [Abstract] [Full-text]
2. Pregnancy outcome after renal allograft transplantation: 15 years experience.
   Eur J Obstet Gynecol Reprod Biol, 121(2): 178-81. [Abstract] [Full-text]
3. Successful ablation of atrioventricular accessory pathway after cardiac transplantation.
   Transpl Int, 17(12): 872-6. [Abstract] [Full-text]
4. Analysis of pig-to-human porcine endogenous retrovirus transmission in a triple-species kidney xenotransplantation model.
   Transpl Int, 17(12): 848-58. [Abstract] [Full-text]
5. The value of routine ophthalmological tests in the screening for lung transplantation.
   Transpl Int, 17(12): 859-61. [Abstract] [Full-text]
6. Effect of IGL-1, a new preservation solution, on kidney grafts (a pre-clinical study).
   Transpl Int, 17(12): 815-21. [Abstract] [Full-text]
7. Detrimental effect of sinusoidal overperfusion after liver resection and partial liver transplantation.
   Transpl Int, 17(12): 862-71. [Abstract] [Full-text]
8. Arterialisation of the portal vein as a model for the induction of hepatic fibrosis: description of microsurgical models in the rat.
   Transpl Int, 17(12): 822-33. [Abstract] [Full-text]
9. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
   Transpl Int, 17(12): 804-9. [Abstract] [Full-text]
10. Lung transplantation for emphysema. Lung hyperinflation: incidence and outcome.
    Transpl Int, 17(12): 810-4. [Abstract] [Full-text]
11. Detection of citrate synthase-reacting autoantibodies after heart transplantation: an epitope mapping study.
    Transpl Int, 17(12): 834-40. [Abstract] [Full-text]
12. The outcome of 400 consecutive liver grafts using the aortic perfusion-only technique.
    Transpl Int, 17(12): 772-8. [Abstract] [Full-text]
13. Strain-specific in vitro cytokine production profiles do not predict rat liver allograft survival.
    Transpl Int, 17(12): 779-86. [Abstract] [Full-text]
14. Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B.
    Transpl Int, 17(12): 746-58. [Abstract] [Full-text]
15. Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.
    Transpl Int, 17(12): 759-66. [Abstract] [Full-text]
16. Sonolucent space posterior to left atrium: unusual echocardiographic appearance in a cardiac transplant patient.
    Echocardiography, 22(7): 603-5. [Abstract] [Full-text]
17. Liver transplantation in HIV-HCV coinfected candidates: what is the most appropriate time for evaluation?
    AIDS Res Hum Retroviruses, 21(7): 599-601. [Abstract] [Full-text]
18. Heart and en-bloc thymus transplantation in miniature swine.
    J Thorac Cardiovasc Surg, 130(2): 554-9. [Abstract] [Full-text]
19. Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing.
    J Thorac Cardiovasc Surg, 130(2): 542-6. [Abstract] [Full-text]
20. Long-term survival in lung transplant recipients after successful preoperative coronary revascularization.
    J Thorac Cardiovasc Surg, 130(2): 538-41. [Abstract] [Full-text]
21. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.
    J Thorac Cardiovasc Surg, 130(2): 528-37. [Abstract] [Full-text]
22. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Ther Apher Dial, 9(4): 285-91. [Abstract] [Full-text]
23. Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation.
    Eur Heart J, 26(16): 1660-5. [Abstract] [Full-text]
24. Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survival.
    Nephrol Dial Transplant, 20: viii8-12. [Abstract] [Full-text]
25. Structural characteristics of impaction allografting for revision total hip arthroplasty.
    Clin Biomech (Bristol, Avon), 20(8): 853-5. [Abstract] [Full-text]
26. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Clin Pharmacol Ther, 78(2): 168-81. [Abstract] [Full-text]
27. Management of cardiovascular disease in the renal transplant recipient.
    Cardiol Clin, 23(3): 331-42. [Abstract] [Full-text]
28. Free radical-dependent dysfunction of small-for-size rat liver grafts: prevention by plant polyphenols.
    Gastroenterology, 129(2): 652-64. [Abstract] [Full-text]
29. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Gastroenterology, 129(2): 494-503. [Abstract] [Full-text]
30. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation.
    Gastroenterology, 129(2): 408-14. [Abstract] [Full-text]
31. Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection.
    J Proteome Res, 4(4): 1192-9. [Abstract] [Full-text]
32. Role of bcl-2 mRNA in homeostatic proliferation in circulating T-cells in human liver transplant patients after T-cell depletion.
    J Surg Res, 127(2): 123-30. [Abstract] [Full-text]
33. Surgical therapy for chronic obstructive pulmonary disease.
    Semin Respir Crit Care Med, 26(2): 167-91. [Abstract] [Full-text]
34. Pulmonary rehabilitation and COPD.
    Semin Respir Crit Care Med, 26(2): 133-41. [Abstract] [Full-text]
35. Initial experience with oral valganciclovir for pre-emptive cytomegalovirus therapy after lung transplantation.
    Wien Klin Wochenschr, 117(13): 480-4. [Abstract] [Full-text]
36. Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients.
    Nephrol Dial Transplant, 20(9): 1970-5. [Abstract] [Full-text]
37. The anterior palate as a donor site in maxillofacial bone grafting: a quantitative anatomic study.
    J Oral Maxillofac Surg, 63(8): 1196-200. [Abstract] [Full-text]
38. Outcome of coronary artery bypass operations in patients with renal insufficiency with and without renal transplantation.
    Chest, 128(2): 855-62. [Abstract] [Full-text]
39. The economic effect of a tertiary hospital-based heart failure program.
    J Am Coll Cardiol, 46(4): 660-6. [Abstract] [Full-text]
40. Retrograde stenting for obstruction of the renal transplant ureter.
    Urology, 66(2): 256-60; discussion 260. [Abstract] [Full-text]
41. Pregnancy in patients with previous successful renal transplantation.
    Int J Gynaecol Obstet, 90(3): 198-202. [Abstract] [Full-text]
42. Monitoring the lung periphery of transplanted lungs.
    Respir Physiol Neurobiol, 148(1): 141-51. [Abstract] [Full-text]
43. Distinct endoplasmic reticulum stress responses are triggered during human liver transplantation.
    J Pathol, 207(1): 111-8. [Abstract] [Full-text]
44. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
    Arch Dermatol, 141(8): 985-93. [Abstract] [Full-text]
45. Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients.
    Arch Dermatol, 141(8): 978-82. [Abstract] [Full-text]
46. For gold, heart rate matters.
    J Heart Lung Transplant, 24(8): 1171-3. [Abstract] [Full-text]
47. Lymphocytic myocarditis after lung transplantation.
    J Heart Lung Transplant, 24(8): 1163-5. [Abstract] [Full-text]
48. Transplantation of yeast-infected cardiac allografts: a report of 2 cases.
    J Heart Lung Transplant, 24(8): 1159-62. [Abstract] [Full-text]
49. Effect of azithromycin on bronchiectasis and pulmonary function in a heart-lung transplant patient with severe chronic allograft dysfunction: a case report.
    J Heart Lung Transplant, 24(8): 1155-8. [Abstract] [Full-text]
50. Symptomatic acute myocardial infarction in a cardiac transplant recipient successfully treated with primary coronary angioplasty: evidence of prognostic importance of chest pain after cardiac transplantation.
    J Heart Lung Transplant, 24(8): 1146-9. [Abstract] [Full-text]
51. Fatty infiltration of right ventricle (adipositas cordis): an unrecognized cause of early graft failure after cardiac transplantation.
    J Heart Lung Transplant, 24(8): 1143-5. [Abstract] [Full-text]
52. Elective transplant pneumonectomy in a 38-year-old man.
    J Heart Lung Transplant, 24(8): 1140-2. [Abstract] [Full-text]
53. Successful lung transplantation from a donor with a saddle pulmonary embolus.
    J Heart Lung Transplant, 24(8): 1137-9. [Abstract] [Full-text]
54. Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD154 monoclonal antibody.
    J Heart Lung Transplant, 24(8): 1118-20. [Abstract] [Full-text]
55. It is time to stop ignoring malignancy in heart transplantation: a call to arms.
    J Heart Lung Transplant, 24(8): 1111-3. [Abstract] [Full-text]
56. Transplantation for myocarditis: a controversy revisited.
    J Heart Lung Transplant, 24(8): 1103-10. [Abstract] [Full-text]
57. Lung transplantation from out-of-hospital non-heart-beating lung donors. one-year experience and results.
    J Heart Lung Transplant, 24(8): 1098-102. [Abstract] [Full-text]
58. Experimental lung transplantation: impact of preservation solution and route of delivery.
    J Heart Lung Transplant, 24(8): 1081-90. [Abstract] [Full-text]
59. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
    J Heart Lung Transplant, 24(8): 1076-80. [Abstract] [Full-text]
60. Upregulation of CD40, CD80, CD83 or CD86 on alveolar macrophages after lung transplantation.
    J Heart Lung Transplant, 24(8): 1067-75. [Abstract] [Full-text]
61. Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens.
    J Heart Lung Transplant, 24(8): 1055-66. [Abstract] [Full-text]
62. Neuroendocrine profiling of humans receiving cardiac allografts.
    J Heart Lung Transplant, 24(8): 1046-54. [Abstract] [Full-text]
63. Neointimal inflammation and adventitial angiogenesis correlate with severity of cardiac allograft vasculopathy in pediatric recipients.
    J Heart Lung Transplant, 24(8): 1039-45. [Abstract] [Full-text]
64. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.
    J Heart Lung Transplant, 24(8): 1033-8. [Abstract] [Full-text]
65. Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis.
    J Heart Lung Transplant, 24(8): 1026-32. [Abstract] [Full-text]
66. Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation.
    J Heart Lung Transplant, 24(8): 1019-25. [Abstract] [Full-text]
67. Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient.
    J Heart Lung Transplant, 24(8): 1014-8. [Abstract] [Full-text]
68. Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients.
    J Heart Lung Transplant, 24(8): 1008-13. [Abstract] [Full-text]
69. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
    J Heart Lung Transplant, 24(8): 998-1007. [Abstract] [Full-text]
70. Prostate cancer after heart transplantation: unicenter case-control study.
    J Heart Lung Transplant, 24(8): 995-7. [Abstract] [Full-text]
71. Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients.
    J Heart Lung Transplant, 24(8): 990-4. [Abstract] [Full-text]
72. Comparison of survival by allocation to medical therapy, surgery, or heart transplantation for ischemic advanced heart failure.
    J Heart Lung Transplant, 24(8): 983-9. [Abstract] [Full-text]
73. Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent.
    Transpl Int, 18(9): 1113-5. [Abstract] [Full-text]
74. Donor transmitted anaplastic carcinoma in a kidney-transplant recipient.
    Transpl Int, 18(9): 1109-12. [Abstract] [Full-text]
75. Benefit of Kupffer cell modulation with glycine versus Kupffer cell depletion after liver transplantation in the rat: effects on postischemic reperfusion injury, apoptotic cell death graft regeneration and survival.
    Transpl Int, 18(9): 1079-89. [Abstract] [Full-text]
76. Prevalence and characteristics of noncompliant behaviour and its risk factors in kidney transplant recipients.
    Transpl Int, 18(9): 1072-8. [Abstract] [Full-text]
77. A retrospective study of the prognostic impact of cytokine secretion in mixed lymphocyte culture on long-term graft function following allogeneic renal transplantation.
    Transpl Int, 18(9): 1067-71. [Abstract] [Full-text]
78. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
    Transpl Int, 18(9): 1054-60. [Abstract] [Full-text]
79. Nocardiosis following solid organ transplantation: a single-centre experience.
    Transpl Int, 18(9): 1048-53. [Abstract] [Full-text]
80. Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients.
    Transpl Int, 18(9): 1036-47. [Abstract] [Full-text]
81. Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus.
    Transpl Int, 18(9): 1028-35. [Abstract] [Full-text]
82. Laparoscopy for living donor nephrectomy--particularities of the currently applied techniques.
    Transpl Int, 18(9): 1019-27. [Abstract] [Full-text]
83. Cyclosporin-induced gingival overgrowth: a clinical-epidemiological evaluation of 121 Italian renal transplant recipients.
    J Periodontol, 76(8): 1259-64. [Abstract] [Full-text]
84. Supratherapeutic response to ezetimibe administered with cyclosporine.
    Ann Pharmacother, 39(9): 1561-5. [Abstract] [Full-text]
85. Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft.
    Biomaterials, 26(35): 7339-49. [Abstract] [Full-text]
86. Endovascular treatment of splenomesenteric-portal vein thromboses during orthotopic liver transplantation.
    J Vasc Interv Radiol, 16(8): 1135-42. [Abstract] [Full-text]
87. Arrhythmias after orthotopic heart transplantation.
    J Card Fail, 11(6): 464-72. [Abstract] [Full-text]
88. Serial measurements of peripheral vascular reactivity and exercise capacity in congestive heart failure and after heart transplantation.
    J Card Fail, 11(6): 447-54. [Abstract] [Full-text]
89. Clinical kidney transplantation: a 50th anniversary review of the first reported series.
    Am J Surg, 190(3): 485-8. [Abstract] [Full-text]
90. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
    Am J Surg, 190(3): 383-7. [Abstract] [Full-text]
91. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Clin Microbiol Infect, 11(9): 736-43. [Abstract] [Full-text]
92. Autogenous bone chips: influence of a new piezoelectric device (Piezosurgery) on chip morphology, cell viability and differentiation.
    J Clin Periodontol, 32(9): 994-9. [Abstract] [Full-text]
93. Interleukin-6 gene polymorphism in renal transplant patients with and without gingival overgrowth.
    J Clin Periodontol, 32(9): 955-8. [Abstract] [Full-text]
94. Hepatitis C and liver transplantation.
    Nature, 436(7053): 973-8. [Abstract] [Full-text]
95. Biopsy of potential cadaveric renal allografts at the time of retrieval.
    Nephrology (Carlton), 10(4): 414-7. [Abstract] [Full-text]
96. Impact of obesity on renal transplant outcomes.
    Nephrology (Carlton), 10(4): 405-13. [Abstract] [Full-text]
97. A follow up study of cytomegalovirus infection in a group of Turkish renal transplant recipients using molecular assays.
    Mem Inst Oswaldo Cruz, 100(3): 263-7. [Abstract] [Full-text]
98. Renal leiomyoma associated with Epstein-Barr virus in a pediatric transplant patient.
    Am J Kidney Dis, 46(2): 351-5. [Abstract] [Full-text]
99. Alloimmune response against donor glutathione S-transferase T1 antigen in renal transplant recipients.
    Am J Kidney Dis, 46(2): 345-50. [Abstract] [Full-text]
100. Intolerance syndrome in failed renal allografts: incidence and efficacy of percutaneous embolization.
     Am J Kidney Dis, 46(2): 339-44. [Abstract] [Full-text]
101. Biliary complications after liver transplantation: the role of endoscopy.
     Endoscopy, 37(9): 857-63. [Abstract] [Full-text]
102. A new alloantigen-independent control for chronic allograft nephropathy rat models.
     J Surg Res, 128(1): 50-4. [Abstract] [Full-text]
103. Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: initial experience.
     Radiology, 236(3): 911-9. [Abstract] [Full-text]
104. Costimulation blockade with belatacept in renal transplantation.
     N Engl J Med, 353(8): 770-81. [Abstract] [Full-text]
105. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients.
     Am J Health Syst Pharm, 62(17): 1775-81. [Abstract] [Full-text]
106. The impact of skin disease following renal transplantation on quality of life.
     Br J Dermatol, 153(3): 574-8. [Abstract] [Full-text]
107. Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling.
     Br J Clin Pharmacol, 60(3): 249-56. [Abstract] [Full-text]
108. Bony press-fit closure of oro-antral fistulas: a technique for pre-sinus lift repair and secondary closure.
     J Oral Maxillofac Surg, 63(9): 1288-94. [Abstract] [Full-text]
109. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts.
     J Am Soc Nephrol, 16(9): 2732-45. [Abstract] [Full-text]
110. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
     J Am Soc Nephrol, 16(9): 2804-12. [Abstract] [Full-text]
111. Emotional distress and quality of life in caregivers of patients awaiting lung transplant.
     J Psychosom Res, 59(1): 1-6. [Abstract] [Full-text]
112. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation.
     J Pediatr, 147(2): 180-5. [Abstract] [Full-text]
113. Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies.
     Biol Blood Marrow Transplant, 11(9): 672-9. [Abstract] [Full-text]
114. Transfusion free surgery: single institution experience of 27 consecutive liver transplants in Jehovah's Witnesses.
     J Am Coll Surg, 201(3): 412-7. [Abstract] [Full-text]
115. Modified Exeter technique in revision hip surgery: does distal fixation of the stem affect allograft transformation?
     J Arthroplasty, 20(4): 473-80. [Abstract] [Full-text]
116. Hamstring tendon versus patellar tendon anterior cruciate ligament reconstruction using biodegradable interference fit fixation: a prospective matched-group analysis.
     Am J Sports Med, 33(9): 1327-36. [Abstract] [Full-text]
117. A 7-year follow-up of patellar tendon and hamstring tendon grafts for arthroscopic anterior cruciate ligament reconstruction: differences and similarities.
     Am J Sports Med, 33(9): 1337-45. [Abstract] [Full-text]
118. Recombinant dimeric MHC antigens protect cardiac allografts from rejection and visualize alloreactive T cells.
     J Leukoc Biol, 78(3): 595-604. [Abstract] [Full-text]
119. Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients.
     J Zhejiang Univ Sci B, 6(9): 885-91. [Abstract] [Full-text]
120. Dose requirements of continuous infusion of rocuronium and atracurium throughout orthotopic liver transplantation in humans.
     J Zhejiang Univ Sci B, 6(9): 869-72. [Abstract] [Full-text]
121. The effect of recombinant human osteogenic protein-1 on allograft incorporation.
     J Bone Joint Surg Br, 87(9): 1292-7. [Abstract] [Full-text]
122. Non-vascularised fibular transfer in the management of defects of long bones after sequestrectomy in children.
     J Bone Joint Surg Br, 87(9): 1259-63. [Abstract] [Full-text]
123. The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival.
     Am J Kidney Dis, 46(3): 537-49. [Abstract] [Full-text]
124. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
     Am J Kidney Dis, 46(3): 529-36. [Abstract] [Full-text]
125. Health disparities in transplantation: focus on the complexity and challenge of renal transplantation in African Americans.
     Med Clin North Am, 89(5): 1003-31, ix. [Abstract] [Full-text]
126. A comparative study of BK and JC virus infections in organ transplant recipients.
     J Med Virol, 77(2): 238-43. [Abstract] [Full-text]
127. Extending options for highly sensitized patients to receive a suitable kidney graft.
     Curr Opin Immunol, 17(5): 536-40. [Abstract] [Full-text]
128. Overcoming the portal steal phenomenon in auxiliary partial orthotopic liver transplantation by modulation of the venous outflow of the native liver.
     Liver Transpl, 11(9): 1140-3. [Abstract] [Full-text]
129. ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia.
     Liver Transpl, 11(9): 1132-5. [Abstract] [Full-text]
130. Quality assurance, efficiency indicators and cost-utility of the evaluation workup for liver transplantation.
     Liver Transpl, 11(9): 1080-5. [Abstract] [Full-text]
131. Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease.
     Liver Transpl, 11(9): 1112-6. [Abstract] [Full-text]
132. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure.
     Liver Transpl, 11(9): 1073-9. [Abstract] [Full-text]
133. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation.
     Liver Transpl, 11(9): 1048-55. [Abstract] [Full-text]
134. Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.
     Liver Transpl, 11(9): 1064-72. [Abstract] [Full-text]
135. Emergency splenic arterial embolization for massive variceal bleeding in liver recipient with left-sided portal hypertension.
     Liver Transpl, 11(9): 1136-9. [Abstract] [Full-text]
136. Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.
     Liver Transpl, 11(9): 1127-31. [Abstract] [Full-text]
137. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
     Liver Transpl, 11(9): 1100-6. [Abstract] [Full-text]
138. Risk factors for Staphylococcus aureus infection in liver transplant recipients.
     Liver Transpl, 11(9): 1093-9. [Abstract] [Full-text]
139. Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders.
     Liver Transpl, 11(9): 1056-63. [Abstract] [Full-text]
140. Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation.
     Eur J Clin Pharmacol, 61(7): 507-16. [Abstract] [Full-text]
141. In vivo study to assess the viability and mass effect of fascia injection in comparison with block fascia graft.
     Aesthetic Plast Surg, 29(4): 304-9. [Abstract] [Full-text]

© 2004-2008 Organ Transplantation Research Today. All Rights Reserved.